Previous Close | 35.03 |
1-Year Change | -16.46% |
6-Months Change | 51.38% |
3-Months Change | 46.26% |
Moving Avg (50d) | 30.075 |
Moving Avg (200d) | 26.91 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 1.66B |
Beta (3-Years) | 1.28 |
Revenue Growth (ttm) | 20.65% |
Net Profit Margin (ttm) | -6.52% |
Return On Assets (ttm) | -4.13% |
EPS (ttm) | -0.54 |
PE Ratio (ttm) | -64.87 |
Dividend Yield | % |
Asset Description: | AtriCure, Inc. |
Predicted Direction: | Buy |
Signal Strength: | Neutral |
Forecast Date: | 2024-11-20 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
35.309 | 34.228 | 33.508 | 32.427 | 30.625 | 28.824 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.